ArticleGastroenterology2019
Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms.
Wuqing Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it